Why the study?
The study was conducted to evaluate the effect of an enhanced recovery after surgery (ERAS) program on length of stay among elective colorectal surgery patients at a safety-net hospital.
Does an Enhanced recovery after surgery (ERAS) protocol reduce length-of-stay in elective colorectal surgery patients?
Does an Enhanced recovery after surgery (ERAS) protocol reduce length-of-stay in elective colorectal surgery patients?
Implementation of an ERAS protocol in a safety-net hospital did not significantly reduce length of stay, though it improved fluid balance and reduced opioid utilization.
ERAS did not reduce LOS in this safety-net cohort; hypothesis-generating and should not yet change practice.
Background: Enhanced recovery after surgery (ERAS) is a multidisciplinary pathway of perioperative patient care. Objective: To evaluate the effect of an ERAS program on length-of-stay (LOS) among elective colorectal surgery patients at a safety-net hospital. Design: Retrospective chart review Setting: 500+ bed in a safety-net hospital. Patients and Methods: Retrospective review of elective colorectal surgery patients comparing those participating in an ERAS protocol to historical-control (HC) patients from the preceding year. Main Outcome Measures: The primary outcome was LOS. Secondary outcomes of interest included opioid utilization, fluid balance throughout the hospital stay, return of bowel function, 30-day complications emergency department visits, and readmissions. Sample Size: 193. Results: ERAS (n = 94) and HC groups (n = 99) were similar with regards to demographics and operations performed. ERAS patients had a longer operating room (OR) time (P = 0.010), however, OR fluid rates were lower for ERAS patients (P < 0.001) with more neutral fluid balance at discharge (closer to 0) (P = 0.006). ERAS patients received fewer opioids in the OR (P < 0.001) and throughout the hospital stay (P = 0.043). Median LOS was 4 days for both groups (P = 0.141) and no difference in 30-day emergency department (ED) visits, readmission, or complications. Conclusions: Benefits of ERAS may not be immediately evident post-implementation. Further study is needed regarding the maintenance of ERAS interventions over time and the impact on patient outcomes. Limitations: Single-center retrospective nature and surgeon turnover during this period. Conflict of Interest: None.
No takes yet. Share an insight, caveat, or question.
Talutis et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: